Prevalence of Chronic Renal Diseases to Augment the Global Apheresis Market duriPosted by Apeksha on July 24th, 2021 Apheresis Market Research Report, By Products (Devices and Disposables), By Procedures (Plateletpheresis, Leukapheresis, Erythrocytapheresis, Plasmapheresis), By Methods (Centrifugation And Filtration), By Application (Oncological Diseases, Renal Diseases, Cardiovascular Diseases, Haematological Diseases, Neurological Diseases, Immunological Diseases) And By End Users (Blood Banks, Hospitals) – Global Forecast to 2027 Market Scenario The global apheresis market is presumed to register 10.2 % CAGR during the forecast period (2017-2023), owing to the increasing prevalence of chronic renal diseases, asserts Market Research Future (MRFR). Apheresis is referred to as the procedure of separating and purifying the blood for treating several renal, neurological, autoimmune, hematological, and other diseases. Regional Insights Geographically, apheresis market span across regions namely, America, Europe, Asia Pacific, and Rest-of-the-World (RoW). Competitive Dashboard The major players operating the global market are Kaneka Corporation (Japan), Terumo BCT Inc. (US), Fresenius Medical Care (Germany), Nikkiso Co. Ltd. (Japan), Asahi Kasei Medical Co. Ltd. (Japan), B. Braun Melsungen AG (Germany), Nikkiso Ltd. (Japan), HemaCare Corporation (US), Cerus Corporation (US), Haemonetics Corporation (US), Kawasumi Laboratories Inc. (Japan), Therakos, Inc. (U.S.), and others. Browse Detailed TOC with COVID-19 Impact Analysis at: https://www.marketresearchfuture.com/reports/apheresis-market-1508 Contact: Akash Anand Market Research Future +1 646 845 9312 Like it? Share it! More by this author |